Arabako Osasun Mentaleko Sarea

2021

1. Antipsychotics as environmental pollutants: An underrated threat?

   Science of the Total Environment, Vol. 769

2. Changing Embodied Dialogical Patterns in Metacognitive Interpersonal Therapy

   Journal of Constructivist Psychology, Vol. 34, Núm. 2, pp. 123-137

3. Clinical, physical, physiological, and cardiovascular risk patterns of adults with schizophrenia: CORTEX-SP study: Characterization of adults with schizophrenia

   Psychiatry Research, Vol. 295

4. Cognitive, community functioning and clinical correlates of the Clinical Assessment Interview for Negative Symptoms (CAINS) in psychotic disorders

   European Archives of Psychiatry and Clinical Neuroscience, Vol. 271, Núm. 8, pp. 1537-1546

5. Cognitive, creative, functional, and clinical symptom improvements in schizophrenia after an integrative cognitive remediation program: a randomized controlled trial

   npj Schizophrenia, Vol. 7, Núm. 1

6. Cross-validation of predictive equation for cardiorespiratory fitness by modified shuttle walk test in adults with schizophrenia: A secondary analysis of the cortex-sp study

   International Journal of Environmental Research and Public Health, Vol. 18, Núm. 21

7. Do cariprazine and brexpiprazole cause impulse control symptoms? A case/non-case study

   European Neuropsychopharmacology, Vol. 50, pp. 107-111

8. Drug pollution & Sustainable Development Goals

   Science of the Total Environment, Vol. 800

9. El cambio de los patrones corporales relacionales en la Terapia Metacognitiva Interpersonal

   Papeles del psicólogo, Vol. 42, Núm. 1, pp. 21-32

10. Environmental pollution with psychiatric drugs

    WORLD JOURNAL OF PSYCHIATRY, Vol. 11, Núm. 10, pp. 791-804

11. Evaluación de las experiencias de tipo psicótico en adolescentes españoles: Baremación del Prodromal Questionnaire-Brief (PQ-B)

    Revista de psicopatología y psicología clínica, Vol. 26, Núm. 1, pp. 35-46

12. Farmakokutsadura eta Garapen Iraunkorrerako 6. Helburua: ur garbia eta saneamendua

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 1, pp. 105-118

13. New forehead device in positional obstructive sleep apnoea: A randomised clinical trial

    Thorax, Vol. 76, Núm. 9, pp. 930-938

14. Pharmacotherapeutic management of Parkinson's disease inpatients: How about asking hospital pharmacists?

    European Journal of Hospital Pharmacy, Vol. 28, Núm. e1, pp. E140-E145

15. Prophylactic laxatives in clozapine-treated patients: A long road ahead

    Revista de Psiquiatria Clinica, Vol. 48, Núm. 1, pp. 66-68

16. SGLT2 Inhibitors and Bladder Cancer: Analysis of Cases Reported in the European Pharmacovigilance Database

    Journal of Clinical Pharmacology, Vol. 61, Núm. 2, pp. 187-192

17. The Patient, Investigator, Nurse, Carer Questionnaire (PINC-Q): a cross-sectional, retrospective, non-interventional study exploring the impact of less frequent medication administration with paliperidone palmitate 3-monthly as maintenance treatment for schizophrenia

    BMC Psychiatry, Vol. 21, Núm. 1

18. The impact of creativity on functional outcome in schizophrenia: a mediational model

    npj Schizophrenia, Vol. 7, Núm. 1

19. The longitudinal effect of antipsychotic burden on psychosocial functioning in first-episode psychosis patients: The role of verbal memory

    Psychological Medicine, Vol. 51, Núm. 12, pp. 2044-2053

20. Tramadol-induced hiccups: a case–noncase study in the European pharmacovigilance database

    Therapeutic Advances in Drug Safety, Vol. 12